Your browser doesn't support javascript.
loading
Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome.
Bergamaschi, A; Tagliabue, E; Sørlie, T; Naume, B; Triulzi, T; Orlandi, R; Russnes, H G; Nesland, J M; Tammi, R; Auvinen, P; Kosma, V-M; Ménard, S; Børresen-Dale, A-L.
Affiliation
  • Bergamaschi A; Department of Genetics, Institute for Cancer Research, Rikshospitalet-Radiumhospitalet Medical Centre, Montebello, Oslo, Norway.
J Pathol ; 214(3): 357-67, 2008 Feb.
Article in En | MEDLINE | ID: mdl-18044827
Subject(s)
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Gene Expression Regulation, Neoplastic / Extracellular Matrix Proteins / Oligonucleotide Array Sequence Analysis / Gene Expression Profiling Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: J Pathol Year: 2008 Document type: Article Affiliation country: Noruega Country of publication: Reino Unido
Search on Google
Add to My VHL
Print
XML
PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Gene Expression Regulation, Neoplastic / Extracellular Matrix Proteins / Oligonucleotide Array Sequence Analysis / Gene Expression Profiling Type of study: Prognostic_studies Limits: Female / Humans Language: En Journal: J Pathol Year: 2008 Document type: Article Affiliation country: Noruega Country of publication: Reino Unido